Roman Trawicki
Net Worth

Last updated:

What is Roman Trawicki net worth?

The estimated net worth of Mr. Roman Trawicki is at least $28,779,590 as of 16 Mar 2022. He owns shares worth $1,281,761 as insider, has earned $12,167,829 from insider trading and has received compensation worth at least $15,330,000 in Zoetis Inc..

What is the salary of Roman Trawicki?

Mr. Roman Trawicki salary is $2,190,000 per year as Executive Vice President and Pres of Global Manufacturing & Supply in Zoetis Inc..

What stocks does Roman Trawicki currently own?

As insider, Mr. Roman Trawicki owns shares in one company:

Company Title Shares Price per share Total value
Zoetis Inc. (ZTS) Executive Vice President and Pres of Global Manufacturing & Supply 8,218 $155.97 $1,281,761

What does Zoetis Inc. do?

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

ZTS logo
ZTS
Zoetis Inc.
$155.97

Roman Trawicki insider trading

Zoetis Inc.

Mr. Roman Trawicki has made 16 insider trades between 2018-2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 23,885 units of ZTS stock on 23 Feb 2018. As of 16 Mar 2022 he still owns at least 8,218 units of ZTS stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 6,000 $87.51 $525,060
Sale
Common Stock 6,000 $188.15 $1,128,900
Option
Stock Option 6,000 N/A N/A
Option
Common Stock 3,486 N/A N/A
Option
Restricted Stock Unit 3,486 N/A N/A
Option
Common Stock 12,022 N/A N/A
Option
Performance Award Unit 12,022 N/A N/A
Option
Common Stock 3,287 $73.24 $240,740
Sale
Common Stock 4,497 $194.14 $873,048
Option
Stock Option 3,287 N/A N/A
Sale
Common Stock 4,492 N/A N/A
Option
Stock Option 3,285 N/A N/A
Option
Common Stock 3,285 N/A N/A
Option
Stock Option 3,285 N/A N/A
Option
Common Stock 3,285 N/A N/A
Sale
Common Stock 4,491 $165 $741,015
Option
Stock Option 3,285 N/A N/A
Option
Common Stock 3,285 N/A N/A
Sale
Common Stock 4,491 N/A N/A
Option
Performance Award Unit 5,409 N/A N/A
Option
Common Stock 9,114 N/A N/A
Option
Restricted Stock Unit 3,705 N/A N/A
Sale
Common Stock 5,501 $165.65 $911,224
Option
Common Stock 4,080 $55.02 $224,482
Option
Stock Option 4,080 $55.02 $224,482
Option
Common Stock 4,079 $55.02 $224,427
Sale
Common Stock 5,499 $137.29 $754,958
Option
Stock Option 4,079 $55.02 $224,427
Option
Stock Option 4,079 $55.02 $224,427
Option
Common Stock 4,079 $55.02 $224,427
Sale
Common Stock 5,499 $130 $714,870
Option
Common Stock 4,079 $55.02 $224,427
Sale
Common Stock 5,499 $143.42 $788,667
Option
Stock Option 4,079 $55.02 $224,427
Option
Performance Award Unit 6,402 N/A N/A
Option
Restricted Stock Unit 4,321 N/A N/A
Option
Common Stock 10,723 N/A N/A
Sale
Common Stock 2,199 $137.41 $302,165
Sale
Common Stock 4,700 $109 $512,300
Option
Stock Option 17,873 $95.1 $1,699,722
Sale
Common Stock 17,873 $95.1 $1,699,722
Option
Common Stock 17,873 $95.1 $1,699,722
Option
Restricted Stock Unit 4,882 N/A N/A
Option
Performance Award Unit 8,137 N/A N/A
Option
Common Stock 13,019 N/A N/A
Sale
Common Stock 8,266 $92.53 $764,853
Option
Stock Option 4,688 $49.12 $230,275
Option
Common Stock 4,688 $49.12 $230,275
Option
Restricted Stock Unit 1,302 N/A N/A
Option
Common Stock 1,302 N/A N/A
Option
Common Stock 8,568 $83.1 $712,001
Sale
Common Stock 8,568 $83.1 $712,001
Option
Stock Option 8,568 $83.1 $712,001
Option
Common Stock 5,454 N/A N/A
Option
Restricted Stock Unit 2,217 N/A N/A
Option
Performance Award Unit 3,237 N/A N/A
Option
Stock Option 23,885 $82 $1,958,570
Option
Common Stock 23,885 $82 $1,958,570
Sale
Common Stock 23,885 $82 $1,958,570
Sale
Common Stock 3,804 $80.32 $305,537
Option
Common Stock 7,178 N/A N/A
Option
Restricted Stock Unit 7,178 N/A N/A